BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3621195)

  • 1. Mechanism of decrease of protein synthesis by sodium cyanate in murine P388 leukemia cells.
    Lazarus P; Panasci LC
    Cancer Res; 1987 Oct; 47(19):5102-7. PubMed ID: 3621195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of administration of sodium cyanate and melphalan on the lifespan of P388 tumor-bearing CD2F1 mice.
    Dufour M; St Germain J; Skalski V; Dorato A; Lazarus P; Panasci LC
    Cancer Chemother Pharmacol; 1984; 12(2):94-7. PubMed ID: 6697430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
    Burres NS; Clement JJ
    Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of 3,4-disuccinyldianhydrogalactitol, N-nitrosourea and their combination on DNA synthesis in normal and mouse P388 tumor cells].
    Sokolova IS; Veres Z; Jakus J; Otvos LL; Gorbacheva LB
    Izv Akad Nauk SSSR Biol; 1989; (4):527-33. PubMed ID: 2794230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
    Avramis VI; Plunkett W
    Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity and nucleic acid binding properties of dercitin, a new acridine alkaloid isolated from a marine Dercitus species sponge.
    Burres NS; Sazesh S; Gunawardana GP; Clement JJ
    Cancer Res; 1989 Oct; 49(19):5267-74. PubMed ID: 2548717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells.
    Ling YH; Priebe W; Perez-Soler R
    Cancer Res; 1993 Apr; 53(8):1845-52. PubMed ID: 8467504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium, calmodulin, and protein content of adriamycin-resistant and -sensitive murine leukemic cells.
    Nair S; Samy TS; Krishan A
    Cancer Res; 1986 Jan; 46(1):229-32. PubMed ID: 3940193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of monovalent cations on the ratio of RNA transcripts from DNA with different repetitive sequences in leukemia P-388 cells].
    Danko IM; Prima VI; Kaz'min SD; Pinchuk VG
    Biokhimiia; 1986 Mar; 51(3):458-62. PubMed ID: 3697419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists.
    Yang JM; Goldenberg S; Gottesman MM; Hait WN
    Cancer Res; 1994 Feb; 54(3):730-7. PubMed ID: 7905786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of harringtonine and its allied alkaloids on the incorporation of labelled amino acids into proteins of transplantable leukemias L-615 and P-388 cells].
    Xu YT; Du CZ; Zhang FR; Ji XJ
    Yao Xue Xue Bao; 1981 Sep; 16(9):661-6. PubMed ID: 7331814
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of sodium cyanate for selective inhibition of protein synthesis in cultured tumor cells.
    Boffa LC; Kozak S; Allfrey VG
    Cancer Res; 1981 Jan; 41(1):60-6. PubMed ID: 6256065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor pharmacokinetics of hexamethylmelamine in CDF1 mice bearing P388 leukemia.
    Dubois J; Atassi G; Hanocq M; Abikhalil F
    Anticancer Res; 1989; 9(1):255-9. PubMed ID: 2495757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of ochratoxin A.
    Dirheimer G; Creppy EE
    IARC Sci Publ; 1991; (115):171-86. PubMed ID: 1820332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics and proposed mechanism of therapeutic action and host toxicity of 9-beta-D-arabinofuranosyl-2-fluoroadenine monophosphate (F-araAMP) in P388 murine leukemia-bearing mice.
    Avramis VI
    Cancer Invest; 1989; 7(2):129-37. PubMed ID: 2477118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine splenocyte migration inhibition assay I. Detection of differential responses to murine leukemia P388 and its adriamycin-resistant subline P388/ADR.
    Nori M; Gothoskar BP
    Neoplasma; 1983; 30(3):287-93. PubMed ID: 6223231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models.
    Mirabelli CK; Johnson RK; Sung CM; Faucette L; Muirhead K; Crooke ST
    Cancer Res; 1985 Jan; 45(1):32-9. PubMed ID: 3917372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophoretic mobility studies on doxorubicin-resistant and -sensitive murine P388 leukemic cells.
    Nair S; Horton A; Leif RC; Krishan A
    Cytometry; 1988 May; 9(3):232-7. PubMed ID: 3163971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
    Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST
    Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of biosynthetic processes in P388 and Ehrlich ascites cells by cloturin.
    Miko M; Krepelka J; Melka M
    Drugs Exp Clin Res; 1988; 14(9):575-80. PubMed ID: 3229320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.